Search clinical trials for: 99mTc-rhAnnexin V-128

Total 14 results

Advanced Accelerator Applications

Terminated

99mTc-rhAnnexin V-128 Imaging for Carotid Atherosclerosis

Carotid Artery Plaque

Canada
Advanced Accelerator Applications

Terminated

99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)

Rheumatoid Arthritis | Ankylosing Spondylitis

Switzerland
Advanced Accelerator Applications

Terminated

99mTc-rhAnnexin V-128 Imaging and Cardiotoxicity in Patients With Early Breast Cancer

Breast Cancer | Doxorubicin Induced Cardiomyopathy

Canada
Advanced Accelerator Applications
Atreus Pharmaceuticals Corporation

Completed

99mTc-rhAnnexin V-128: a First In Man Study in Healthy Volunteers

Healthy Adult Volunteers

Canada
Advanced Accelerator Applications

Terminated

99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis (Annexin 03)

Spondyloarthritis

United States
Institut National de la Santé Et de la Recherche...
Advanced Accelerator Applications

Terminated

Assessment of Radiolabeled rhAnnexin V-128 in Infective Endocarditis (AnnIE)

Thrombosis | Endocarditis

France
Assistance Publique - Hôpitaux de Paris

Withdrawn

99m Tc-ANNexin-V-128 Scintigraphy for the Identification of Complicated Carotid Atherosclerotic Plaques (ANNICA)

Carotid Atherosclerosis | Atherosclerotic Plaque
Columbia University
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Imaging of Peri-operative (periOP) Lung Injury

Acute Lung Injury | Chronic Obstructive Pulmonary Disease (COPD)

United States
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

The Influence of the 34C>T Variant in the AMPD1 Gene Ischemic Tolerance

AMPD | Ischemic Tolerance
Actavis Inc.

Completed

A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting Conditions

Healthy

Canada
Novo Nordisk A/S

Completed

A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 Diabetes

Healthy | Diabetes | Diabetes Mellitus, Type 1

Germany
Actavis Inc.

Completed

A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions

Healthy

Canada
Stanford University

Completed

Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases

Cancer

United States
Mount Vernon Cancer Centre at Mount Vernon Hospital

Unknown

Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma

Lymphoma

United Kingdom

Search clinical trials for: 99mTc-rhAnnexin V-128

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations